158 related articles for article (PubMed ID: 1643892)
1. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients.
Malacrida R; Fritz ME; Suter PM; Crevoisier C
Crit Care Med; 1992 Aug; 20(8):1123-6. PubMed ID: 1643892
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients.
Ethuin F; Boudaoud S; Leblanc I; Troje C; Marie O; Levron JC; Le Moing JP; Assoune P; Eurin B; Jacob L
Intensive Care Med; 2003 Nov; 29(11):1916-20. PubMed ID: 12923616
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
[TBL] [Abstract][Full Text] [Related]
4. Midazolam infusion for basal sedation in intensive care: absence of accumulation.
Michalk S; Moncorge C; Fichelle A; Huot O; Servin F; Farinotti R; Desmonts JM
Intensive Care Med; 1988; 15(1):37-41. PubMed ID: 3230199
[TBL] [Abstract][Full Text] [Related]
5. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
[TBL] [Abstract][Full Text] [Related]
6. Continuous infusion of lorazepam versus medazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective.
Swart EL; van Schijndel RJ; van Loenen AC; Thijs LG
Crit Care Med; 1999 Aug; 27(8):1461-5. PubMed ID: 10470750
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of long-term infusion of midazolam in critically ill patients--preliminary results.
Dirksen MS; Vree TB; Driessen JJ
Anaesth Intensive Care; 1987 Nov; 15(4):440-4. PubMed ID: 3122596
[TBL] [Abstract][Full Text] [Related]
8. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs.
Barrientos-Vega R; Mar Sánchez-Soria M; Morales-García C; Robas-Gómez A; Cuena-Boy R; Ayensa-Rincon A
Crit Care Med; 1997 Jan; 25(1):33-40. PubMed ID: 8989173
[TBL] [Abstract][Full Text] [Related]
9. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study.
Pohlman AS; Simpson KP; Hall JB
Crit Care Med; 1994 Aug; 22(8):1241-7. PubMed ID: 8045143
[TBL] [Abstract][Full Text] [Related]
10. The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients.
Driessen JJ; Vree TB; Guelen PJ
Acta Anaesthesiol Belg; 1991; 42(3):149-55. PubMed ID: 1767626
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of midazolam during continuous infusion in critically ill neonates.
Jacqz-Aigrain E; Daoud P; Burtin P; Maherzi S; Beaufils F
Eur J Clin Pharmacol; 1992; 42(3):329-32. PubMed ID: 1577053
[TBL] [Abstract][Full Text] [Related]
12. [Continuous infusion of ketamine and midazolam for prolonged sedation in the intensive care unit].
Kawamata M; Ujike Y; Miyabe M; Kobayashi I; Arakawa J; Namiki A; Imaizumi H; Yamaya K
Masui; 1991 Dec; 40(12):1793-8. PubMed ID: 1770572
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit.
Hartwig S; Roth B; Theisohn M
Eur J Pediatr; 1991 Sep; 150(11):784-8. PubMed ID: 1959542
[TBL] [Abstract][Full Text] [Related]
14. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit.
Barr J; Donner A
Crit Care Clin; 1995 Oct; 11(4):827-47. PubMed ID: 8535981
[TBL] [Abstract][Full Text] [Related]
15. Optimizing sedation following major vascular surgery: a double-blind study of midazolam administered by continuous infusion.
Miller DR; Martineau RJ; Hull KA; Vallée F; LeBel M
Can J Anaesth; 1994 Sep; 41(9):782-93. PubMed ID: 7954994
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability?
Oldenhof H; de Jong M; Steenhoek A; Janknegt R
Clin Pharmacol Ther; 1988 Mar; 43(3):263-9. PubMed ID: 3345618
[TBL] [Abstract][Full Text] [Related]
17. Decreased plasma albumin concentration results in increased volume of distribution and decreased elimination of midazolam in intensive care patients.
Vree TB; Shimoda M; Driessen JJ; Guelen PJ; Janssen TJ; Termond EF; van Dalen R; Hafkenscheid JC; Dirksen MS
Clin Pharmacol Ther; 1989 Nov; 46(5):537-44. PubMed ID: 2582710
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of midazolam and its main metabolite 1-hydroxymidazolam in intensive care patients.
Boulieu R; Lehmann B; Salord F; Fisher C; Morlet D
Eur J Drug Metab Pharmacokinet; 1998; 23(2):255-8. PubMed ID: 9725490
[TBL] [Abstract][Full Text] [Related]
19. Propofol reduces the distribution and clearance of midazolam.
Lichtenbelt BJ; Olofsen E; Dahan A; van Kleef JW; Struys MM; Vuyk J
Anesth Analg; 2010 Jun; 110(6):1597-606. PubMed ID: 20435936
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting.
Zomorodi K; Donner A; Somma J; Barr J; Sladen R; Ramsay J; Geller E; Shafer SL
Anesthesiology; 1998 Dec; 89(6):1418-29. PubMed ID: 9856717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
